|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0280 EUR | -5.41% |
|
-2.78% | -10.83% |
| 25-10-15 | GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report | CI |
| 25-10-15 | Geneuro SA postpones publication of half-yearly financial report | RE |
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -47.92 | -55.4 | -34.52 | -61.53 | -100.64 | |||||
Return on Total Capital | -124.29 | -106.24 | -50.28 | -85.25 | -211.83 | |||||
Return On Equity % | -5.46K | -5.86K | -131.62 | -386.76 | 239.67 | |||||
Return on Common Equity | -5.46K | -5.86K | -131.62 | -386.76 | 239.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | - | - | - | - | - | |||||
SG&A Margin | - | - | - | - | - | |||||
EBITDA Margin % | - | - | - | - | - | |||||
EBITA Margin % | - | - | - | - | - | |||||
EBIT Margin % | - | - | - | - | - | |||||
Income From Continuing Operations Margin % | - | - | - | - | - | |||||
Net Income Margin % | - | - | - | - | - | |||||
Net Avail. For Common Margin % | - | - | - | - | - | |||||
Normalized Net Income Margin | - | - | - | - | - | |||||
Levered Free Cash Flow Margin | - | - | - | - | - | |||||
Unlevered Free Cash Flow Margin | - | - | - | - | - | |||||
Asset Turnover | ||||||||||
Asset Turnover | - | - | - | - | - | |||||
Fixed Assets Turnover | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.66 | 3.29 | 3.22 | 2.75 | 0.37 | |||||
Quick Ratio | 0.63 | 3.2 | 2.17 | 2.11 | 0.29 | |||||
Operating Cash Flow to Current Liabilities | -0.9 | -3.08 | -2.21 | -3.95 | -1.62 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -163.37 | 28.41 | 80.5 | 486.42 | -99.19 | |||||
Total Debt / Total Capital | 257.81 | 22.12 | 44.6 | 82.95 | -12.29K | |||||
LT Debt/Equity | -9.28 | 23.09 | 73.01 | 445.3 | -93.77 | |||||
Long-Term Debt / Total Capital | 14.65 | 17.98 | 40.45 | 75.94 | -11.62K | |||||
Total Liabilities / Total Assets | 155.41 | 47.53 | 61.36 | 87.24 | 316.57 | |||||
EBIT / Interest Expense | -20.34 | -122.04 | - | - | - | |||||
EBITDA / Interest Expense | -19.56 | -117.15 | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | -19.67 | -117.45 | - | - | - | |||||
Total Debt / EBITDA | -0.98 | -0.18 | -0.64 | -0.62 | -0.97 | |||||
Net Debt / EBITDA | -0.3 | 0.62 | 0.26 | -0.13 | -0.84 | |||||
Total Debt / (EBITDA - Capex) | -0.98 | -0.18 | -0.64 | -0.61 | -0.97 | |||||
Net Debt / (EBITDA - Capex) | -0.3 | 0.62 | 0.26 | -0.13 | -0.84 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | - | - | - | - | - | |||||
Gross Profit, 1 Yr. Growth % | - | - | - | - | - | |||||
EBITDA, 1 Yr. Growth % | 11.36 | -1.93 | -14.7 | 73.53 | 21.55 | |||||
EBITA, 1 Yr. Growth % | 11.15 | -1.85 | -14.66 | 72.96 | 21.48 | |||||
EBIT, 1 Yr. Growth % | 11.15 | -1.85 | -14.66 | 72.96 | 21.48 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 13.6 | -5.27 | -23.93 | 78.94 | 20.96 | |||||
Net Income, 1 Yr. Growth % | 13.6 | -5.27 | -23.93 | 78.94 | 20.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.6 | -5.27 | -23.93 | 78.91 | 20.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 13.79 | -30.77 | -28.8 | 59.34 | 16.36 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 572.79 | 112.84 | -15.51 | -18.51 | -25.26 | |||||
Total Assets, 1 Yr. Growth % | -33.11 | 11.83 | 19.3 | -8.53 | -44.54 | |||||
Tangible Book Value, 1 Yr. Growth % | -244.9 | -168.6 | -15.18 | -91.25 | -4.71K | |||||
Common Equity, 1 Yr. Growth % | -193.76 | -205.88 | -12.14 | -69.79 | -1.04K | |||||
Cash From Operations, 1 Yr. Growth % | -43.57 | -27.49 | -5.61 | 92.9 | -22.31 | |||||
Capital Expenditures, 1 Yr. Growth % | 65.25 | -57.54 | 88.78 | 42.08 | -78.22 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -54.4 | -39.35 | 39.09 | -13.72 | -50.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -56.24 | -37.49 | 40.45 | -13.72 | -50.75 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | - | - | - | - | - | |||||
Gross Profit, 2 Yr. CAGR % | - | - | - | - | - | |||||
EBITDA, 2 Yr. CAGR % | 25.49 | 4.51 | -15.95 | 26.08 | 45.24 | |||||
EBITA, 2 Yr. CAGR % | 25.15 | 4.44 | -15.85 | 25.87 | 44.96 | |||||
EBIT, 2 Yr. CAGR % | 25.15 | 4.44 | -15.85 | 25.87 | 44.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 27.31 | 3.74 | -15.11 | 16.67 | 47.12 | |||||
Net Income, 2 Yr. CAGR % | 27.31 | 3.74 | -15.11 | 16.67 | 47.12 | |||||
Normalized Net Income, 2 Yr. CAGR % | 27.31 | 3.74 | -15.11 | 16.66 | 47.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 27.47 | -11.24 | -29.79 | 6.51 | 36.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 132.62 | 278.41 | 34.1 | -17.02 | -21.96 | |||||
Total Assets, 2 Yr. CAGR % | -44.37 | -13.51 | 15.5 | 4.47 | -28.77 | |||||
Tangible Book Value, 2 Yr. CAGR % | -26.95 | -0.3 | -23.72 | -72.76 | 100.8 | |||||
Common Equity, 2 Yr. CAGR % | -36.84 | -0.36 | -3.55 | -48.48 | 68.63 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.75 | -36.03 | -17.27 | 34.94 | 22.42 | |||||
Capital Expenditures, 2 Yr. CAGR % | 28.34 | -16.24 | -10.47 | 63.78 | -44.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 291.35 | -47.41 | -2.65 | 8.05 | -34.82 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 293.12 | -47.7 | -0.62 | 8.58 | -34.82 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | - | - | - | - | - | |||||
Gross Profit, 3 Yr. CAGR % | - | - | - | - | - | |||||
EBITDA, 3 Yr. CAGR % | -9.82 | 15.59 | -7.68 | 9.6 | 24.55 | |||||
EBITA, 3 Yr. CAGR % | -9.76 | 15.41 | -7.67 | 9.55 | 24.39 | |||||
EBIT, 3 Yr. CAGR % | -9.76 | 15.41 | -7.67 | 9.55 | 24.39 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -12.46 | 15.36 | -6.45 | 8.84 | 18.08 | |||||
Net Income, 3 Yr. CAGR % | -12.46 | 15.36 | -6.45 | 8.84 | 18.08 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.37 | 15.36 | -6.45 | 8.84 | 18.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -13.95 | 4 | -17.53 | -7.74 | 9.7 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 63.96 | 125.83 | 129.57 | 13.59 | -19.86 | |||||
Total Assets, 3 Yr. CAGR % | -37.11 | -29.79 | -3.73 | 6.86 | -15.41 | |||||
Tangible Book Value, 3 Yr. CAGR % | -28.71 | -28.47 | -5.53 | -62.94 | 50.66 | |||||
Common Equity, 3 Yr. CAGR % | -34.66 | -24.97 | -4.45 | -34.5 | 35.69 | |||||
Cash From Operations, 3 Yr. CAGR % | -11.33 | -2.1 | -27.17 | 9.7 | 12.25 | |||||
Capital Expenditures, 3 Yr. CAGR % | -26.08 | -11.24 | 9.82 | 4.43 | -16.41 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 17.76 | 110.21 | -24.39 | -7.34 | -16.85 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.19 | 112.98 | -24.39 | -6.06 | -16.57 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | - | |||||
Gross Profit, 5 Yr. CAGR % | - | - | - | - | - | |||||
EBITDA, 5 Yr. CAGR % | 31.86 | 15.36 | -12.32 | 15.7 | 12.25 | |||||
EBITA, 5 Yr. CAGR % | 32.5 | 15.34 | -12.25 | 15.54 | 12.16 | |||||
EBIT, 5 Yr. CAGR % | 32.5 | 15.34 | -12.25 | 15.54 | 12.16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 39.73 | 14.84 | -13.53 | 15.89 | 12.12 | |||||
Net Income, 5 Yr. CAGR % | 39.73 | 14.84 | -13.53 | 15.89 | 12.12 | |||||
Normalized Net Income, 5 Yr. CAGR % | 33.56 | 14.96 | -11.13 | 15.88 | 12.12 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 34.08 | 3.86 | -20.67 | 5 | 0.79 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 78.2 | 84.64 | 51.29 | 51.31 | 49.1 | |||||
Total Assets, 5 Yr. CAGR % | 0.75 | -12.73 | -19.79 | -17.69 | -14.66 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.8 | 23.03 | -26.76 | -51.38 | 27.73 | |||||
Common Equity, 5 Yr. CAGR % | -3.55 | 26.62 | -23.64 | -35.45 | 19.92 | |||||
Cash From Operations, 5 Yr. CAGR % | 27.39 | -9.54 | -13.75 | 11.31 | -10.36 | |||||
Capital Expenditures, 5 Yr. CAGR % | 65.99 | -17.94 | -20.19 | 13.41 | -16.34 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.3 | 1.96 | 9.13 | 64.88 | -29.14 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 21.29 | 1.71 | 9.15 | 66.54 | -29.14 |
- Stock Market
- Equities
- GNRO Stock
- Financials GeNeuro SA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















